• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏去神经术的长期疗效:解剖导向的间隔入路。

Long-Term Outcome of Cardiac Denervation Procedures: The Anatomically Guided Septal Approach.

机构信息

Arrhythmia Unit-Heart Institute (Incor), University of São Paulo Medical School, São Paulo, Brazil.

Arrhythmia Unit-Heart Institute (Incor), University of São Paulo Medical School, São Paulo, Brazil.

出版信息

JACC Clin Electrophysiol. 2023 Aug;9(8 Pt 1):1344-1353. doi: 10.1016/j.jacep.2023.01.032. Epub 2023 Mar 22.

DOI:10.1016/j.jacep.2023.01.032
PMID:37558291
Abstract

BACKGROUND

Functional bradycardia is a challenging condition that affects a healthy population. Ganglionated plexus ablation has emerged as a therapeutic alternative to avoid a pacemaker.

OBJECTIVES

The purpose of this study is to evaluate long-term effects of anatomically guided cardiac denervation.

METHODS

This is a prospective longitudinal study that included 36 patients with symptomatic functional bradycardia. Electroanatomic reconstruction of both atria was carried out, and the main septal ganglionated plexi were anatomically located and targeted.

RESULTS

Ablation endpoints were: 1) heart rate increment; 2) Wenckebach cycle length shortening; and 3) atrio-Hisian (AH) interval shortening. A sinus node denervation was obtained in all patients with an increment of 21.6% in the mean heart rate. All patients presented a negative atropine test after ablation. Twenty-eight (77.7%) patients presented immediate sings of atrioventricular node denervation, with a shortening of 15.6% of mean Wenckebach cycle length and 15.9% of the mean AH interval. All heart rate variability parameters showed a significant reduction after 12 months, enduring after 18 months. Thirty (83.3%) patients remained free of events after a mean follow-up of 52.1 ± 35.2 months. One patient (2.77%) presented acute sinus node artery occlusion during ablation with persistent sinus dysfunction and had a pacemaker implantation; 3 (8.3%) other patients evolved with sinus tachycardia, and 4 (11.1%) patients presented syncope recurrence during follow-up, 3 (8.3%) of them requiring a pacemaker implantation. No other tachyarrhythmia was observed.

CONCLUSIONS

The anatomically guided septal approach is an effective technique for syncope prevention, promoting long-lasting autonomic changes. No significant proarrhythmia effect has been observed during the long-term follow-up.

摘要

背景

功能性心动过缓是一种影响健康人群的具有挑战性的病症。神经节丛消融术已成为一种替代起搏器的治疗选择。

目的

本研究旨在评估解剖指导下心内去神经术的长期效果。

方法

这是一项前瞻性纵向研究,共纳入 36 例有症状的功能性心动过缓患者。对两心房进行电解剖重建,并对主间隔神经节丛进行解剖定位和靶向消融。

结果

消融终点为:1)心率增加;2)文氏周期长度缩短;和 3)房室结(AH)间期缩短。所有患者均实现了窦房结去神经,平均心率增加 21.6%。所有患者消融后均行阿托品试验均为阴性。28 例(77.7%)患者即刻出现房室结去神经,平均文氏周期长度缩短 15.6%,平均 AH 间期缩短 15.9%。所有心率变异性参数在 12 个月后均显著降低,并在 18 个月后持续降低。30 例(83.3%)患者在平均 52.1±35.2 个月的随访后无事件发生。1 例(2.77%)患者在消融过程中出现窦性结动脉闭塞,持续性窦性功能障碍,并植入起搏器;3 例(8.3%)患者出现窦性心动过速,4 例(11.1%)患者在随访期间出现晕厥复发,其中 3 例(8.3%)需要植入起搏器。未观察到其他快速性心律失常。

结论

解剖指导下的间隔方法是预防晕厥的有效技术,可长期持续地改变自主神经功能。在长期随访中未观察到明显的致心律失常作用。

相似文献

1
Long-Term Outcome of Cardiac Denervation Procedures: The Anatomically Guided Septal Approach.心脏去神经术的长期疗效:解剖导向的间隔入路。
JACC Clin Electrophysiol. 2023 Aug;9(8 Pt 1):1344-1353. doi: 10.1016/j.jacep.2023.01.032. Epub 2023 Mar 22.
2
Targets and End Points in Cardiac Autonomic Denervation Procedures.心脏去神经支配手术中的靶点与终点
Circ Arrhythm Electrophysiol. 2017 Feb;10(2):e004638. doi: 10.1161/CIRCEP.116.004638.
3
Unifocal Right-Sided Ablation Treatment for Neurally Mediated Syncope and Functional Sinus Node Dysfunction Under Computed Tomographic Guidance.在 CT 引导下对神经介导性晕厥和功能性窦房结功能障碍进行单侧右侧消融治疗。
Circ Arrhythm Electrophysiol. 2018 Sep;11(9):e006604. doi: 10.1161/CIRCEP.118.006604.
4
Long-Term Evaluation of the Vagal Denervation by Cardioneuroablation Using Holter and Heart Rate Variability.使用 Holter 监测和心率变异性评估心脏去神经支配的长期效果。
Circ Arrhythm Electrophysiol. 2020 Dec;13(12):e008703. doi: 10.1161/CIRCEP.120.008703. Epub 2020 Nov 16.
5
Selective vagal innervation principles of ganglionated plexi: step-by-step cardioneuroablation in a patient with vasovagal syncope.选择性迷走神经支配原理的神经节丛:血管迷走性晕厥患者的逐步心神经消融。
J Interv Card Electrophysiol. 2021 Apr;60(3):453-458. doi: 10.1007/s10840-020-00757-3. Epub 2020 May 11.
6
Differential effect of ganglionic plexi ablation in a patient with neurally mediated syncope and intermittent atrioventricular block.神经节丛消融术对一名患有神经介导性晕厥和间歇性房室传导阻滞患者的不同影响。
Europace. 2017 Jan;19(1):119-126. doi: 10.1093/europace/euw100. Epub 2016 May 18.
7
Bradyarrhythmia in a marathonist: Cardiac vagal denervation as alternative treatment.一名马拉松运动员的缓慢性心律失常:心脏迷走神经去神经支配作为替代治疗方法。
Rev Port Cardiol. 2023 Mar;42(3):277.e1-277.e7. doi: 10.1016/j.repc.2023.01.017. Epub 2023 Jan 21.
8
Right anterior ganglionated plexus: The primary target of cardioneuroablation?右侧前神经节丛:心脏神经消融的主要靶点?
Heart Rhythm. 2019 Oct;16(10):1545-1551. doi: 10.1016/j.hrthm.2019.07.018. Epub 2019 Jul 19.
9
Initial experience with ablation of the innervation surrounding sinus and atrioventricular nodes to treat paroxysmal bradyarrhythmia.消融围绕窦房结和房室结的神经支配治疗阵发性缓慢性心律失常的初步经验。
Chin Med J (Engl). 2020 Jan 20;133(2):134-140. doi: 10.1097/CM9.0000000000000595.
10
Cardioneuroablation for pediatric patients with functional sinus node dysfunction and paroxysmal atrioventricular block.心脏神经消融术治疗功能性窦房结功能障碍和阵发性房室传导阻滞的儿科患者。
J Cardiovasc Electrophysiol. 2024 Feb;35(2):221-229. doi: 10.1111/jce.16145. Epub 2023 Dec 1.

引用本文的文献

1
Cardioneuroablation for Asystolic Reflex Syncope: How to Identify the Best Candidate and How to Predict Success.心脏神经消融术治疗心脏停搏反射性晕厥:如何识别最佳候选患者以及如何预测成功率。
Arrhythm Electrophysiol Rev. 2025 Aug 12;14:e17. doi: 10.15420/aer.2025.25. eCollection 2025.
2
Inappropriate Sinus Tachycardia Following Cardioneuroablation for Reflex Syncope: A Case Report and Review of the Literature Illustrating this Underappreciated Adverse Effect.心脏神经消融治疗反射性晕厥后出现的不适当窦性心动过速:一例报告及文献复习,揭示这种未被充分认识的不良反应
Arrhythm Electrophysiol Rev. 2025 Jun 13;14:e12. doi: 10.15420/aer.2025.01. eCollection 2025.
3
The Efficacy of Cardioneuroablation versus Midodrine in Patients with Vasovagal Syncope: Design and Rationale for the CAMPAIGN Trial.
心脏神经消融术与米多君治疗血管迷走性晕厥患者的疗效比较:CAMPAIGN试验的设计与原理
J Interv Card Electrophysiol. 2025 Mar;68(2):257-265. doi: 10.1007/s10840-025-02029-4. Epub 2025 Mar 21.
4
Cardiac parasympathetic denervation reduces hypoxic tachycardia, baroreflex sensitivity and heart rate variability in humans.心脏副交感神经去神经支配可降低人类的低氧性心动过速、压力反射敏感性和心率变异性。
Sci Rep. 2025 Feb 24;15(1):6633. doi: 10.1038/s41598-025-91214-6.
5
Cardioneuroablation for reflex syncope or functional bradyarrhytmias: new insight from a single center experience.用于反射性晕厥或功能性缓慢性心律失常的心脏神经消融术:来自单中心经验的新见解
Front Cardiovasc Med. 2025 Jan 13;11:1526825. doi: 10.3389/fcvm.2024.1526825. eCollection 2024.
6
Cardioneuroablation for the treatment of reflex syncope and functional bradyarrhythmias: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS) and the Latin American Heart Rhythm Society (LAHRS).心脏神经消融术治疗反射性晕厥和功能性心动过缓:欧洲心脏病学会心律协会 (EHRA)、心律学会 (HRS)、亚太心律学会 (APHRS) 和拉丁美洲心律学会 (LAHRS) 的科学声明。
Europace. 2024 Aug 3;26(8). doi: 10.1093/europace/euae206.
7
Procedural and Intermediate-term Results of the Electroanatomical-guided Cardioneuroablation for the Treatment of Supra-Hisian Second- or Advanced-degree Atrioventricular Block: the PIRECNA multicentre registry.电生理引导下心神经消融治疗希氏束上方二度或三度房室传导阻滞的程序和中期结果:PIRECNA 多中心注册研究。
Europace. 2024 Jul 2;26(7). doi: 10.1093/europace/euae164.
8
Cardioneuroablation for vasovagal syncope: insights on patients' selection, centre settings, procedural workflow and endpoints-results from an European Heart Rhythm Association survey.心脏神经消融治疗血管迷走性晕厥:患者选择、中心设置、程序流程和终点的见解——来自欧洲心律协会调查的结果。
Europace. 2024 May 2;26(5). doi: 10.1093/europace/euae106.
9
Cardioneuroablation for Cardioinhibitory Vasovagal Syncope: Rationale, Approaches, and Its Role in Long-Term Management.用于心脏抑制型血管迷走性晕厥的心脏神经消融术:原理、方法及其在长期管理中的作用。
Curr Cardiovasc Risk Rep. 2024 Apr;18(4):55-64. doi: 10.1007/s12170-024-00736-7. Epub 2024 Apr 16.
10
Cardiac conduction diseases: understanding the molecular mechanisms to uncover targets for future treatments.心脏传导疾病:了解分子机制,为未来的治疗方法寻找靶点。
Expert Opin Ther Targets. 2024 May;28(5):385-400. doi: 10.1080/14728222.2024.2351501. Epub 2024 May 13.